semaglutide pathway Spotlight on the Mechanism of Action of CagriSema vs Semaglutide: Dual Amylin/GLP-1

It activates both GLP-1 and GIP receptors

Trends Cardiovasc Med

It is not yet FDA-approved (still in Phase 3 trials as of February 2026), so it is only available through research suppliers

The specialists at Primary Care of Clear Lake can guide patients on how to maximize the benefits of semaglutide, offering support and advice on diet and exercise to help patients achieve their weight loss goals effectively and sustainably

They will even help you with additional precautions that may be necessary

Recent research and clinical studies have shown that Semaglutide GLP-1 effectively helps patients lose excess weight, control blood sugar levels, reduce waist circumference, and maintain a healthy BMI